Skip to content

Home Care for Sale – Vallexa Advisors

Leaders in Healthcare Mergers & Acquisitions

  • Home
  • Home Care for Sale
  • Contact Us

Tag: business valuation

Professional Vallexa Advisors banner showcasing global healthcare M&A expertise with a blue networked globe symbolizing connection, trust, and growth.

Hospice Valuation amid Fraud Crackdowns, Shutdowns & Policy Shifts: What Owners Need to Know

November 11, 2025 by homecare

Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether you’re selling a hospice, home health, or senior-care business, our team helps you navigate the complexities of valuation, compliance, and buyer negotiations — ensuring you achieve maximum value for your legacy.

Read More
Hospice valuation graphic by Vallexa Advisors showing healthcare M&A value growth

Hospice Valuation: How to Accurately Value and Maximize Worth of a Hospice Business

October 15, 2025 by homecare

Hospice valuation is where compassion meets numbers. Learn how buyers price hospice agencies, what drives multiples, and how Vallexa Advisors helps owners prepare, position, and sell for premium value with certainty. Ready for a confidential consult? We’re here to lead.

Read More

Recently Listed

  • Hospice Valuation amid Fraud Crackdowns, Shutdowns & Policy Shifts: What Owners Need to Know
  • How the 2026 Final Rule and HOPE Tool Shape Hospice Valuation
  • Hospice Valuation: Understanding the Process and Maximizing Your Agency’s Worth
  • Home Care Agency for Sale in the Central State of Pennsylvania
  • Comprehensive Guide to Selling Senior Healthcare Businesses: Assisted Living, Hospice, Home Health & More

HomeCare.Forsale

Specialized healthcare M&A advisory services for Home Care, Home Health, and Hospice agencies nationwide.

Phone: (586) 623-5616

Email: [email protected]

Address: Detroit, Michigan & Las Vegas, Nevada USA

© 2025 Home Care for Sale – Vallexa Advisors. All rights reserved.

This website does not constitute an offer to sell securities. All information is confidential and proprietary.